References
1. Zamorano JL. Lancellotti P, Muñoz DR, et al; ESC Scientific Document Group. 2016. ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J 2016:37:2768-280.
2. Jurcut R, Wildiers H, Ganame J, et al. Strain rate imaging defects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr 2008:21:1283–9.
3. Santoro C, Arpino G, Esposito R, et al. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility. Eur Heart J – Cardiovasc Imaging 2017:18(8):930-936.
4. Sawaya H, Sebag IA, Plana JC, et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 2012:5:596-603.
5. Geyer H, Caracciolo G, Abe H, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiography 2010;23:351-369.
6. Lester SJ, Tajik AJ, Nishimura RA, et al. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later.J Am Coll Cardiol 2008:51:679–89.
7. Plana JC, Galderisi M, Barac A, et al. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2014:911–39.
8. Nagueh SF, Middleton KJ, Kopelen HA, et al. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997:30:1527–33.
9. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 2000:102:1788–94.
10. Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal non-invasive assessment of LV filling pressures: A comparison of tissue Doppler echocardiography and BNP in patients with pulmonary artery catheters. Circulation 2004:109:2432–9.
11. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016:Apr;29(4):277-314.
12. Lassen MCH, Biering-Sørensen SR, Olsen FJ, et al. Ratio of transmitral early filling velocity to early diastolic strain rate predicts long-term risk of cardiovascular morbidity and mortality in the general population. Eur Heart J 2019:Feb7;40(6):518-525.
13. Ersbøll M, Andersen MJ, Valeur N, et al. Early diastolic strain rate in relation to systolic and diastolic function and prognosis in acute myocardial infarction: a two-dimensional speckle-tracking study. Eur Heart J Volume 35, Issue 10, 7 March 2014, Pages 648–656.
14. Morris DA, Boldt LH, Eichstädt H, et al. Myocardial systolic and diastolic performance derived by 2-dimensinoal speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction. Circ Heart Fail 2012:Sep1;5(5):610-20.
15. Ponikowski P, Voors AA, Anker SD, et al; ESC Scientific Document Group. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J Volume 37, Issue 27, 14 July 2016,2129–2200.
16. Lang RM, Bierig M, Devereux RB, et al; American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006:7:79–10817.
17. Teo SG, Yang H, Chai P, et al. Impact of left ventricular diastolic dysfunction on left atrial volume and function: a volumetric analysis. Eur J Echocardiogr 2010:11:38–43
18. Charbonnel C, Convers-Domart R, Rigaudeau S. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity. Eur Heart J Cardiovasc Imaging 2017:18:392-401.
19. Laufer-Perl M, Arnold JH, Mor L, et al. The association of reduced global longitudinal strain with cancer therapy-related cardiac dysfunction among patients receiving cancer therapy. Clin Res Cardiol 2019:Jun18.
20. Stoodley PW, Richards DA, Boyd A, et al. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy. Eur Heart J Cardiovasc Imaging 2013:March;14(3):228-34.
21. Park JH, Marwick TH. Use and Limitations of E/e’ to Assess Left Ventricular Filling Pressure by Echocardiography. J Cardiovasc Ultrasound 2011:Dec;19(4):169-173.
22. Wang J, Khoury DS, Thohan V, et al. Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation 2007:Mar 20;115(11):1376-83.
23. Lee JH, Park JH. Strain Analysis of the Right Ventricle Using Two-dimensional Echocardiography. J Cardiovasc Imaging 2018:Sep;26(3):111-124.
24. Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003:289:194–202.
25. Laufer-Perl M, Derakhshesh M, Milwidsky A, et al. Usefulness of global longitudinal strain for early identification of subclinical left ventricular dysfunction in patients with active cancer. Am J Cardiol 2018;00:1-6.
26. Ohtani K, Fujino T, Ide T, et al. Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity. Clin Res Cardiol 108:600–611.
27. Tocchetti CG, Cadeddu C, Di Lisi D, et al. From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview. Antioxid Redox Signal 2019:30(18):2110–2153.
28. Hare JL, Brown JK, Leano R, et al. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J 2009:158:294–301.
29. Ho E, Brown A, Barrett P, et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 96:701–707,2010.
30. Pizzino F, Vizzari G, Qamar R, et al. Multimodality imaging in cardiooncology. J Oncol 2015:263950.
Figure 1 legend: Measurement of Diastolic strain time (ms).
A figure that shows how Diastolic strain time (ms) was calculated.
Figure 2 legend: ROC curves for change in Basal Diastolic time alone and as part of the multivariate model for prediction of significant global longitudinal strain (GLS) decrease.
A graph showing ROC curves for predicting significant GLS change between the third and first echo using (green) Basal diastolic time (Dst) change alone with an AUC of 0.726, 95% CI [0.515, 0.937] and (blue) using the entire Multivariate model with an AUC of 0.950, 95%CI [0.888, 1], p value for differences between AUCs: 0.0
AUC of the ROC for Basal Dst change alone showed statistically significant, although modest comparing to the entire model, supporting that other parts of the model show a different aspect of GLS reduction prediction.
Abbreviations : AUC, area under curve; CI, confidence interval; GLS, global longitudinal strain; ROC, receiver operating characteristic;